CYP3A4 and benign prostatic hyperplasia: The association between CYP3A4 and VDRTaqI SNPs and the risk of developing PRCa have been investigated in this study by determining the variant genotype frequencies of both SNPs in 400 patients with BPH who have been followed clinically for a median of 11 years.